212 related articles for article (PubMed ID: 17252574)
21. [Clinical features and diagnosis of langerhans cell hyperplasia].
Zhang K; Zeng H; Chen WQ
Ai Zheng; 2006 Jan; 25(1):88-91. PubMed ID: 16405758
[TBL] [Abstract][Full Text] [Related]
22. Langerhans' cell histiocytosis: paediatric head and neck study.
al-Ammar AY; Tewfik TL; Bond M; Schloss MD
J Otolaryngol; 1999 Oct; 28(5):266-72. PubMed ID: 10579156
[TBL] [Abstract][Full Text] [Related]
23. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study.
Donadieu J; Rolon MA; Thomas C; Brugieres L; Plantaz D; Emile JF; Frappaz D; David M; Brauner R; Genereau T; Debray D; Cabrol S; Barthez MA; Hoang-Xuan K; Polak M;
J Pediatr; 2004 Mar; 144(3):344-50. PubMed ID: 15001940
[TBL] [Abstract][Full Text] [Related]
24. Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients.
Morimoto A; Kobayashi R; Maeda M; Asami K; Bessho F; Imashuku S;
Pediatr Blood Cancer; 2008 Apr; 50(4):931-2; author reply 932. PubMed ID: 17729246
[No Abstract] [Full Text] [Related]
25. [Langerhans-cell histiocytosis (histiocytosis X); 20-year experience in the Emma Kinderziekenhuis, 1969-1988].
Egeler RM; de Kraker J; Voûte PA
Ned Tijdschr Geneeskd; 1993 May; 137(19):955-60. PubMed ID: 8497330
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis.
Bernstrand C; Cederlund K; Sandstedt B; Ahström L; Lundell M; Dahlquist G; Henter JI
Med Pediatr Oncol; 2001 Apr; 36(4):459-68. PubMed ID: 11260569
[TBL] [Abstract][Full Text] [Related]
27. Langerhans cell histiocytosis in children less than 2 years of age.
Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
[TBL] [Abstract][Full Text] [Related]
28. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.
Guyot-Goubin A; Donadieu J; Barkaoui M; Bellec S; Thomas C; Clavel J
Pediatr Blood Cancer; 2008 Jul; 51(1):71-5. PubMed ID: 18260117
[TBL] [Abstract][Full Text] [Related]
29. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for diabetes insipidus in langerhans cell histiocytosis.
Grois N; Pötschger U; Prosch H; Minkov M; Arico M; Braier J; Henter JI; Janka-Schaub G; Ladisch S; Ritter J; Steiner M; Unger E; Gadner H;
Pediatr Blood Cancer; 2006 Feb; 46(2):228-33. PubMed ID: 16047354
[TBL] [Abstract][Full Text] [Related]
31. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998.
Alston RD; Tatevossian RG; McNally RJ; Kelsey A; Birch JM; Eden TO
Pediatr Blood Cancer; 2007 May; 48(5):555-60. PubMed ID: 16652350
[TBL] [Abstract][Full Text] [Related]
32. Histiocytosis-X in Saudi children.
al-Mulhim I; Sabbah RS; al-Akkad S
Indian J Cancer; 1991 Jun; 28(2):53-60. PubMed ID: 1937547
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Langerhans cell histiocytosis in children: a population-based study.
Stålemark H; Laurencikas E; Karis J; Gavhed D; Fadeel B; Henter JI
Pediatr Blood Cancer; 2008 Jul; 51(1):76-81. PubMed ID: 18266220
[TBL] [Abstract][Full Text] [Related]
34. Langerhans cell histiocytosis in Turkish children.
Tokuç G; Boran P; Oktem S
Turk J Pediatr; 2009; 51(4):344-9. PubMed ID: 19950841
[TBL] [Abstract][Full Text] [Related]
35. Outcome in children with pulmonary Langerhans cell Histiocytosis.
Braier J; Latella A; Balancini B; Castaños C; Rosso D; Chantada G; Ripoli M; Goldberg J
Pediatr Blood Cancer; 2004 Dec; 43(7):765-9. PubMed ID: 15390304
[TBL] [Abstract][Full Text] [Related]
36. Langerhans cell histiocytosis of bone in children and adolescents.
Ghanem I; Tolo VT; D'Ambra P; Malogalowkin MH
J Pediatr Orthop; 2003; 23(1):124-30. PubMed ID: 12499958
[TBL] [Abstract][Full Text] [Related]
37. Langerhans cell histiocytosis: 40 years' experience.
Maria Postini A; del Prever AB; Pagano M; Rivetti E; Berger M; Asaftei SD; Barat V; Andreacchio A; Fagioli F
J Pediatr Hematol Oncol; 2012 Jul; 34(5):353-8. PubMed ID: 22627580
[TBL] [Abstract][Full Text] [Related]
38. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center.
Yağci B; Varan A; Cağlar M; Söylemezoğlu F; Sungur A; Orhan D; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Hematol Oncol; 2008 Jun; 25(5):399-408. PubMed ID: 18569842
[TBL] [Abstract][Full Text] [Related]
39. High incidence of hearing loss in long-term survivors of multisystem Langerhans cell histiocytosis.
Nanduri V; Tatevossian R; Sirimanna T
Pediatr Blood Cancer; 2010 Mar; 54(3):449-53. PubMed ID: 19813249
[TBL] [Abstract][Full Text] [Related]
40. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
